ÂÜÀòÂÒÂ×

Allison Jeynes-Ellis, MD, FFPM (UK), is a clinician with more than 25 years of senior leadership experience in the pharmaceutical industry. As CEO of our portfolio company Avillion LLP, which specializes in co-development and financing of late-stage pharmaceuticals, Allison is responsible for identifying high-potential opportunities to fund programs to approval. Previously, she led development at Wyeth, BMS, and Novartis and has secured numerous U.S. and EU drug approvals. Allison serves as a non-executive director of Agenus Inc and Anaveon.